×

2021년도 Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05 J Cancer Res Clin Oncol

2021년도 The combination of trametinib, a MEK inhibitor, and temsirolimus, an mTOR inhibitor, radiosensitizes lung cancer cells Anticancer Res

2020년도 Radiation induces autophagy via histone H4 lysine 20 trimethylation in non-small cell lung cancer cells Anticancer Res

2020년도 Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Curr Med Res Opin

2019년도 Factors that predict clinical benefit of EGFR TKI therapy in patients with EGFR wild-type lung adenocarcinoma Tuberc Respir Dis

2018년도 Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells Cell Oncol

2017년도 Altered expression of cellular proliferation, apoptosis and the cell cycle-related genes in lung cancer cells with acquired resistance to EGFR tyrosine kinase inhibitors Oncol Lett